{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:42:10Z","timestamp":1791726130434,"version":"4.3.4"},"reference-count":212,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.intimp.2025.115455","type":"journal-article","created":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T17:22:04Z","timestamp":1757265724000},"page":"115455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Host-directed immunotherapy to enhance treatment of Mycobacterium tuberculosis infection"],"prefix":"10.1016","volume":"165","author":[{"given":"Ren","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingrui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115455_bb0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijtb.2020.02.005","article-title":"A systemic review on tuberculosis","volume":"67","author":"Natarajan","year":"2020","journal-title":"Indian J. Tuberc."},{"key":"10.1016\/j.intimp.2025.115455_bb0010","series-title":"Global Tuberculosis Report 2024","year":"2024"},{"key":"10.1016\/j.intimp.2025.115455_bb0015","series-title":"Global Tuberculosis Report 2020","year":"2020"},{"key":"10.1016\/j.intimp.2025.115455_bb0020","series-title":"Global Tuberculosis Report 2023","year":"2023"},{"key":"10.1016\/j.intimp.2025.115455_bb0025","first-page":"e898","article-title":"The global burden of tuberculosis mortality in children: a mathematical modelling study, lancet glob","volume":"5","author":"Dodd","year":"2017","journal-title":"Health"},{"key":"10.1016\/j.intimp.2025.115455_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1578658","article-title":"Global burden and trend of tuberculosis in children and adolescents (under 15\u00a0years old) from 1990 to 2021, with projections to 2040","volume":"13","author":"Liang","year":"2025","journal-title":"Front. Public Health"},{"issue":"2023","key":"10.1016\/j.intimp.2025.115455_bb0035","first-page":"1331","article-title":"Notes from the field: undiagnosed tuberculosis during pregnancy resulting in a neonatal death - United States","volume":"72","author":"Miele","year":"2021","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.intimp.2025.115455_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1062963","article-title":"Mycobacterium tuberculosis-macrophage interaction: molecular updates","volume":"13","author":"Bo","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2025.115455_bb0045","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.chom.2023.09.010","article-title":"Mycobacterium tuberculosis suppresses host DNA repair to boost its intracellular survival","volume":"31","author":"Liu","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.intimp.2025.115455_bb0050","doi-asserted-by":"crossref","first-page":"13326","DOI":"10.1074\/jbc.272.20.13326","article-title":"Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7","volume":"272","author":"Via","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.115455_bb0055","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00018-019-03353-5","article-title":"Host defense mechanisms against Mycobacterium tuberculosis","volume":"77","author":"Chai","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2025.115455_bb0060","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TNMI7-0040-2017","article-title":"Chemotherapy of tuberculosis","volume":"5","author":"Dobbs","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.intimp.2025.115455_bb0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/joim.12780","article-title":"Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis","volume":"284","author":"Lange","year":"2018","journal-title":"J. Intern. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2025.115455_bb0070","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.ijid.2022.02.043","article-title":"Delamanid-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"124","author":"Nasiri","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.intimp.2025.115455_bb0075","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Nix-TB trial team, treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115455_bb0080","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.drudis.2021.09.003","article-title":"Opportunities for overcoming tuberculosis: emerging targets and their inhibitors","volume":"27","author":"Yang","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.intimp.2025.115455_bb0085","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijtb.2023.04.026","article-title":"Effect of adjunct vitamin D treatment in vitamin D deficient pulmonary tuberculosis patients: a randomized, double blind, active controlled clinical trial","volume":"71","author":"Chandra","year":"2024","journal-title":"Indian J. Tuberc."},{"key":"10.1016\/j.intimp.2025.115455_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cjtee.2023.11.003","article-title":"The expression mechanism of programmed cell death 1 ligand 1 and its role in immunomodulatory ability of mesenchymal stem cells","volume":"27","author":"Chen","year":"2024","journal-title":"Chin. J. Traumatol."},{"key":"10.1016\/j.intimp.2025.115455_bb0095","doi-asserted-by":"crossref","first-page":"2102512","DOI":"10.1183\/13993003.02512-2021","article-title":"The paradox of immune checkpoint inhibition re-activating tuberculosis","volume":"60","author":"Ahmed","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2025.115455_bb0100","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/CCM.0000000000003685","article-title":"Immune checkpoint inhibition in Sepsis: a phase 1b randomized, placebo-controlled, single ascending dose study of Antiprogrammed cell death-ligand 1 antibody (BMS-936559)","volume":"47","author":"Hotchkiss","year":"2019","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115455_bb0105","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","article-title":"Immune evasion and provocation by Mycobacterium tuberculosis","volume":"20","author":"Chandra","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.intimp.2025.115455_bb0110","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1038\/s41467-023-44152-8","article-title":"Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy","volume":"14","author":"Gress","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115455_bb0115","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1038\/s41467-025-61826-7","article-title":"Macrophage-T cell interactions promote SLAMF1 expression for enhanced TB defense","volume":"16","author":"Krishna Prasad","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115455_bb0120","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1080\/21645515.2021.2007711","article-title":"BCG vaccination strategies against tuberculosis: updates and perspectives","volume":"17","author":"Qu","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.intimp.2025.115455_bb0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41590-023-01700-0","article-title":"BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance","volume":"25","author":"Lee","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0130","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/pathogens11111228","article-title":"Mycobacterium tuberculosis transmission in high-incidence settings\u2014new paradigms and insights","volume":"11","author":"Coleman","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.intimp.2025.115455_bb0135","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41467-022-28506-2","article-title":"Early alveolar macrophage response and IL-1R-dependent T cell priming determine transmissibility of Mycobacterium tuberculosis strains","volume":"13","author":"Lovey","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115455_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2020.126674","article-title":"Human tuberculosis and Mycobacterium tuberculosis complex: a review on genetic diversity, pathogenesis and omics approaches in host biomarkers discovery","volume":"246","author":"Kanabalan","year":"2021","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.intimp.2025.115455_bb0145","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41423-020-0502-z","article-title":"New insights into the evasion of host innate immunity by Mycobacterium tuberculosis","volume":"17","author":"Chai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0150","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1146\/annurev-immunol-093019-010426","article-title":"The innate immune response to Mycobacterium tuberculosis infection","volume":"39","author":"Ravesloot-Ch\u00e1vez","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0155","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11274-023-03636-x","article-title":"Clinical manifestations and immune response to tuberculosis","volume":"39","author":"Carabal\u00ed-Isajar","year":"2023","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.intimp.2025.115455_bb0160","first-page":"58","article-title":"From immunology to artificial intelligence: revolutionizing latent tuberculosis infection diagnosis with machine learning","volume":"10","author":"Li","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.intimp.2025.115455_bb0165","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.celrep.2019.12.015","article-title":"Mycobacterium tuberculosis limits host glycolysis and IL-1\u03b2 by restriction of PFK-M via MicroRNA-21","volume":"30","author":"Hackett","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2025.115455_bb0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00018-023-04914-5","article-title":"Revolutionizing control strategies against Mycobacterium tuberculosis infection through selected targeting of lipid metabolism","volume":"80","author":"Kim","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2025.115455_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102366","article-title":"Mitochondrial reactive oxygen species: double agents in Mycobacterium tuberculosis infection","volume":"84","author":"Ellzey","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0180","article-title":"MicroRNAs as immune regulators and biomarkers in tuberculosis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0185","article-title":"Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on MicroarrayData analysis, molecular docking, and dynamic simulation","volume":"41","author":"Dinh","year":"2025","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.intimp.2025.115455_bb0190","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00141-20","article-title":"Mechanisms of drug-induced tolerance in Mycobacterium tuberculosis","volume":"34","author":"Goossens","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.intimp.2025.115455_bb0195","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2321336121","article-title":"Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbits","volume":"121","author":"Datta","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2024","key":"10.1016\/j.intimp.2025.115455_bb0200","article-title":"Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention","volume":"5","author":"Zhuang","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.intimp.2025.115455_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102172","article-title":"Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics","volume":"70","author":"Kaur","year":"2022","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.intimp.2025.115455_bb0210","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1007\/s00253-021-11406-8","article-title":"Research progress on toll-like receptor signal transduction and its roles in antimicrobial immune responses","volume":"105","author":"Xia","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.intimp.2025.115455_bb0215","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00011-024-01864-x","article-title":"Recognition of Mycobacterium tuberculosis by macrophage toll-like receptor and its role in autophagy","volume":"73","author":"Wei","year":"2024","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2025.115455_bb0220","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.115455_bb0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.intimp.2025.115455_bb0230","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fped.2019.00350","article-title":"Immune response to Mycobacterium tuberculosis: a narrative review","volume":"7","author":"de Martino","year":"2019","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.intimp.2025.115455_bb0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pccm.2023.10.007","article-title":"Epithelial stem cells and niches in lung alveolar regeneration and diseases","volume":"2","author":"Zhang","year":"2024","journal-title":"Chinese Medical Journal Pulmonary and Critical Care Medicine"},{"key":"10.1016\/j.intimp.2025.115455_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032125","article-title":"The role of alveolar epithelial cells in initiating and shaping pulmonary immune responses: communication between innate and adaptive immune systems","volume":"7","author":"Chuquimia","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.115455_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111063","article-title":"Mycobacteria develop biofilms on airway epithelial cells and promote mucosal barrier disruption","volume":"27","author":"Barclay","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.intimp.2025.115455_bb0250","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1164\/rccm.201910-1977OC","article-title":"Differential responses to targeting matrix metalloproteinase 9 in idiopathic pulmonary fibrosis","volume":"203","author":"Espindola","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115455_bb0255","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3390\/vaccines10101740","article-title":"Epigenetics in tuberculosis: immunomodulation of host immune response","volume":"10","author":"Khadela","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.intimp.2025.115455_bb0260","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.179.4.2060","article-title":"Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin","volume":"179","author":"Liu","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0265","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.115455_bb0270","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/cbf.3780","article-title":"Macrophage efferocytosis in health and disease","volume":"41","author":"Razi","year":"2023","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.intimp.2025.115455_bb0275","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0280","article-title":"Iron, copper, and zinc homeostasis in the Battle between macrophage and Mycobacterium tuberculosis","author":"Yang","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2025.115455_bb0285","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s44280-024-00065-9","article-title":"Phagocytosis: strategies for macrophages to hunt Mycobacterium tuberculosis","volume":"2","author":"Liu","year":"2024","journal-title":"One Health Advances"},{"key":"10.1016\/j.intimp.2025.115455_bb0290","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.3389\/fimmu.2018.02637","article-title":"Neutrophils: innate effectors of TB resistance?","volume":"9","author":"Kroon","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0295","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3389\/fimmu.2018.00903","article-title":"Differential effect of viable versus necrotic neutrophils on Mycobacterium tuberculosis growth and cytokine induction in whole blood","volume":"9","author":"Lowe","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0300","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3390\/vaccines11030631","article-title":"Neutrophils in Mycobacterium tuberculosis","volume":"11","author":"Alcantara","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.intimp.2025.115455_bb0305","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3390\/v13112318","article-title":"The roles of neutrophils in cytokine storms","volume":"13","author":"Chan","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2025.115455_bb0310","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3390\/biom12081148","article-title":"Human pulmonary tuberculosis: understanding the immune response in the Bronchoalveolar system","volume":"12","author":"Herrera","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2025.115455_bb0315","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.2020009417","article-title":"Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis","volume":"138","author":"Wang","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2025.115455_bb0320","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41419-024-06892-3","article-title":"Neutrophil extracellular traps characterize caseating granulomas","volume":"15","author":"Zlatar","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.115455_bb0325","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.chom.2017.09.003","article-title":"Tuberculosis-induced necrosis of infected neutrophils promotes bacterial growth following phagocytosis by macrophages","volume":"22","author":"Dallenga","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.intimp.2025.115455_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101672","article-title":"Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies","volume":"65","author":"Tiwari","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0335","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41423-020-0465-0","article-title":"Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses","volume":"17","author":"Hilligan","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0340","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.tube.2019.02.003","article-title":"Association between polymorphisms of cytokine genes and secretion of IL-12p70, IL-18, and IL-27 by dendritic cells in patients with pulmonary tuberculosis","volume":"115","author":"Urazova","year":"2019","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.intimp.2025.115455_bb0345","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1038\/s41467-024-52863-9","article-title":"MINCLE and TLR9 agonists synergize to induce Th1\/Th17 vaccine memory and mucosal recall in mice and non-human primates","volume":"15","author":"Woodworth","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115455_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biology10010001","article-title":"C-type lectin CD209L\/L-SIGN and CD209\/DC-SIGN: cell adhesion molecules turned to pathogen recognition receptors","volume":"10","author":"Rahimi","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.intimp.2025.115455_bb0355","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","article-title":"Dendritic cell migration in inflammation and immunity","volume":"18","author":"Liu","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0360","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41577-019-0139-2","article-title":"Immunometabolism and natural killer cell responses","volume":"19","author":"O\u2019Brien","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0365","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12967-024-05033-w","article-title":"Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy","volume":"22","author":"Miao","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2025.115455_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2023.127393","article-title":"Immune checkpoint modulating T cells and NK cells response to Mycobacterium tuberculosis infection","volume":"273","author":"Qin","year":"2023","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.intimp.2025.115455_bb0375","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.immuni.2024.03.007","article-title":"The conceptual foundations of innate immunity: taking stock 30 years later","volume":"57","author":"Pradeu","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.115455_bb0380","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.chom.2018.12.006","article-title":"Innate and adaptive immune memory: an evolutionary continuum in the host\u2019s response to pathogens","volume":"25","author":"Netea","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.intimp.2025.115455_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101431","article-title":"Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis","volume":"50","author":"Scriba","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0390","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.imlet.2018.04.001","article-title":"Impact of antiretroviral and tuberculosis therapies on CD4 + and CD8 + HIV\/M. Tuberculosis-specific T-cell in co-infected subjects","volume":"198","author":"Chiacchio","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2025.115455_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.895179","article-title":"The role of CD4+CD8+ T cells in HIV infection with tuberculosis","volume":"10","author":"Zou","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.intimp.2025.115455_bb0400","doi-asserted-by":"crossref","first-page":"2101780","DOI":"10.1183\/13993003.01780-2021","article-title":"M ycobacterium tuberculosis -specific CD4 T-cell scoring discriminates tuberculosis infection from disease","volume":"60","author":"Mantei","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2025.115455_bb0405","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00297-24","article-title":"Polycytotoxic T cells mediate antimicrobial activity against intracellular Mycobacterium tuberculosis","volume":"93","author":"Zumwinkel","year":"2025","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2025.115455_bb0410","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03020-22","article-title":"Use of the human Granulysin transgenic mice to evaluate the role of Granulysin expression by CD8 T cells in immunity to Mycobacterium tuberculosis","volume":"13","author":"Thakur","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.intimp.2025.115455_bb0415","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.intimp.2025.115455_bb0420","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ccell.2022.05.017","article-title":"Innate-like T cells: a promising asset in anti-cancer immunity","volume":"40","author":"Molgora","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2025.115455_bb0425","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molimm.2020.12.007","article-title":"Mouse models illuminate MAIT cell biology","volume":"130","author":"Wang","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0430","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fimmu.2019.00206","article-title":"Mucosal-associated invariant T cell levels are reduced in the peripheral blood and lungs of children with active pulmonary tuberculosis","volume":"10","author":"Malka-Ruimy","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-1775-5_1","article-title":"Genetic Analysis of iNKT cell development and function","volume":"2388","author":"Sahler","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.intimp.2025.115455_bb0440","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41577-020-0345-y","article-title":"Thymic development of unconventional T cells: how NKT cells, MAIT cells and \u03b3\u03b4 T cells emerge","volume":"20","author":"Pellicci","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0445","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41392-023-01653-8","article-title":"\u0393\u03b4 T cells: origin and fate, subsets, diseases and immunotherapy","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.115455_bb0450","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115455_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.681105","article-title":"B cell metabolism and autophagy in autoimmunity","volume":"12","author":"Raza","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0460","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-020-00446-2","article-title":"Transcriptional regulation of memory B cell differentiation","volume":"21","author":"Laidlaw","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0465","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3390\/vaccines11050955","article-title":"Role of B cells in Mycobacterium tuberculosis infection","volume":"11","author":"Stewart","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.intimp.2025.115455_bb0470","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41467-021-20930-0","article-title":"Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis","volume":"12","author":"Watson","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115455_bb0475","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.chom.2013.02.009","article-title":"Antibody-mediated immunity against tuberculosis: implications for vaccine development","volume":"13","author":"Achkar","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.intimp.2025.115455_bb0480","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.4049\/jimmunol.1003189","article-title":"A novel human IgA monoclonal antibody protects against tuberculosis","volume":"186","author":"Balu","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0485","article-title":"Antibodies as key mediators of protection against Mycobacterium tuberculosis","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0490","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MCP.0000000000000575","article-title":"Precision medicine in the clinical management of respiratory tract infections including multidrug-resistant tuberculosis: learning from innovations in immuno-oncology","volume":"25","author":"Rao","year":"2019","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.intimp.2025.115455_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(21)00012-4","article-title":"Cell therapy for tuberculosis and infectious diseases?","volume":"2","author":"Dumiak","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.intimp.2025.115455_bb0500","article-title":"Mesenchymal stem cells and tuberculosis: clinical challenges and opportunities","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0505","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.3390\/cancers15245737","article-title":"Natural killer T cell diversity and immunotherapy","volume":"15","author":"Tognarelli","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2025.115455_bb0510","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3389\/fimmu.2020.02107","article-title":"Harnessing unconventional T cells for immunotherapy of tuberculosis","volume":"11","author":"La Manna","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0515","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41423-023-01034-9","article-title":"Mesenchymal stem\/stromal cells (MSCs): origin, immune regulation, and clinical applications","volume":"20","author":"Zhou","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0520","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.637725","article-title":"Immunomodulatory properties of mesenchymal stromal cells: an update","volume":"9","author":"M\u00fcller","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2025.115455_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4184\/asj.2016.10.1.1","article-title":"New bone formation in tuberculous-infected vertebral body defect after Administration of Bone Marrow Stromal Cells in rabbit model","volume":"10","author":"Rahyussalim","year":"2016","journal-title":"Asian Spine Journal"},{"key":"10.1016\/j.intimp.2025.115455_bb0530","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.3390\/biomedicines11082229","article-title":"Comparison of autografts and biodegradable 3D-printed composite scaffolds with Osteoconductive properties for tissue regeneration in bone tuberculosis","volume":"11","author":"Vinogradova","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2025.115455_bb0535","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.3390\/biomedicines10123062","article-title":"The use of mesenchymal stem cells in the complex treatment of kidney tuberculosis (experimental study)","volume":"10","author":"Muraviov","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2025.115455_bb0540","first-page":"108","article-title":"Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial, lancet","volume":"2","author":"Skrahin","year":"2014","journal-title":"Respir. Med."},{"key":"10.1016\/j.intimp.2025.115455_bb0545","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1038\/s41467-020-16877-3","article-title":"Mesenchymal stem cells offer a drug-tolerant and immune-privileged niche to Mycobacterium tuberculosis","volume":"11","author":"Jain","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115455_bb0550","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1400347","article-title":"The issue of heterogeneity of MSC-based advanced therapy medicinal products-a review","volume":"12","author":"\u010cesnik","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2025.115455_bb0555","article-title":"Mesenchymal stem cells and tuberculosis: clinical challenges and opportunities","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0560","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41577-018-0034-2","article-title":"Tissue-specific functions of invariant natural killer T cells","volume":"18","author":"Crosby","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0565","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/s12276-023-01024-x","article-title":"Invariant natural killer T cells in lung diseases","volume":"55","author":"Jeong","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115455_bb0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000239","article-title":"Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria","volume":"4","author":"Sada-Ovalle","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2025.115455_bb0575","doi-asserted-by":"crossref","first-page":"28633","DOI":"10.18632\/oncotarget.5764","article-title":"Antigen-specific human NKT cells from tuberculosis patients produce IL-21 to help B cells for the production of immunoglobulins","volume":"6","author":"Wu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2025.115455_bb0580","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1073\/pnas.1811380116","article-title":"Immunization of V\u03b32V\u03b42 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates","volume":"116","author":"Shen","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.115455_bb0585","doi-asserted-by":"crossref","first-page":"eade3525","DOI":"10.1126\/sciimmunol.ade3525","article-title":"NK-like CD8+ \u03b3\u03b4 T cells are expanded in persistent Mycobacterium tuberculosis infection","volume":"8","author":"Roy Chowdhury","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.intimp.2025.115455_bb0590","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.4049\/jimmunol.1602019","article-title":"Adoptive transfer of Phosphoantigen-specific \u03b3\u03b4 T cell subset attenuates Mycobacterium tuberculosis infection in nonhuman Primates","volume":"198","author":"Qaqish","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.756495","article-title":"Allogeneic V\u03b39V\u03b42 T-cell therapy promotes pulmonary lesion repair: an open-label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis","volume":"12","author":"Liang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0600","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12967-023-03944-8","article-title":"BCG-induced trained immunity: history, mechanisms and potential applications","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2025.115455_bb0605","doi-asserted-by":"crossref","DOI":"10.1093\/oxfimm\/iqab015","article-title":"TB or not to be: what specificities and impact do antibodies have during tuberculosis?","volume":"2","author":"Hermann","year":"2021","journal-title":"Oxf Open Immunol"},{"key":"10.1016\/j.intimp.2025.115455_bb0610","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167960","article-title":"Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan","volume":"8","author":"Liu","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2025.115455_bb0615","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41423-020-0465-0","article-title":"Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses","volume":"17","author":"Hilligan","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0620","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41577-018-0028-0","article-title":"Antibodies and tuberculosis: finally coming of age?","volume":"18","author":"Li","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0625","article-title":"Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity","volume":"13","author":"S. P, R. A, T. K, N. Ap, H. S, D. M, T. B, J. L, R. Pm, R. Ud, B. S, B. R","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.115455_bb0630","article-title":"From growth factor to central mediator of tissue inflammation","volume":"45","author":"B. B, T. S, G. M, GM-CSF","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.115455_bb0635","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3389\/fimmu.2020.01599","article-title":"GM-CSF dependent differential control of Mycobacterium tuberculosis infection in human and mouse macrophages: is macrophage source of GM-CSF critical to tuberculosis immunity?","volume":"11","author":"Mishra","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0640","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.859116","article-title":"Human macrophages exhibit GM-CSF dependent restriction of Mycobacterium tuberculosis infection via regulating their self-survival, Differentiation and Metabolism","volume":"13","author":"Mishra","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0645","doi-asserted-by":"crossref","first-page":"2301233","DOI":"10.1183\/13993003.01233-2023","article-title":"Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients","volume":"63","author":"Campo","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2025.115455_bb0650","article-title":"Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosis","volume":"18","author":"Ym","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0655","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s11427-012-4368-x","article-title":"Immunotherapy using IL-2 and GM-CSF is a potential treatment for multidrug-resistant Mycobacterium tuberculosis","volume":"55","author":"Zhang","year":"2012","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.intimp.2025.115455_bb0660","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.molmed.2022.04.010","article-title":"Therapeutic potential of interleukin-2 in autoimmune diseases","volume":"28","author":"Yuan","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2025.115455_bb0665","article-title":"Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: a systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.115455_bb0670","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1164\/rccm.200211-1359OC","article-title":"Uganda-Case Western Reserve University research collaboration, randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis","volume":"168","author":"Johnson","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115455_bb0675","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/430914","article-title":"Reconsidering adjuvant immunotherapy for tuberculosis","volume":"41","author":"Wallis","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2025.115455_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113683","article-title":"Role of interferon-gamma (IFN-\u03b3) and IFN-\u03b3 receptor 1\/2 (IFN\u03b3R1\/2) in regulation of immunity, infection, and cancer development: IFN-\u03b3-dependent or independent pathway","volume":"155","author":"Ding","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.115455_bb0685","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1038\/s41467-020-19412-6","article-title":"Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis","volume":"11","author":"Moreira-Teixeira","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115455_bb0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005667","article-title":"CD4 T cell-derived IFN-\u03b3 plays a minimal role in control of pulmonary Mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease","volume":"12","author":"Sakai","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2025.115455_bb0695","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"MVA85A 020 trial study team, safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.115455_bb0700","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1473-3099(23)00501-7","article-title":"TB042 study team, safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial","volume":"24","author":"Wajja","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.intimp.2025.115455_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2022.102198","article-title":"Transient, inhaled gene therapy with gamma interferon mitigates pathology induced by host response in a mouse model of tuberculosis","volume":"134","author":"Bharti","year":"2022","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.intimp.2025.115455_bb0710","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.859116","article-title":"Human macrophages exhibit GM-CSF dependent restriction of Mycobacterium tuberculosis infection via regulating their self-survival, Differentiation and Metabolism","volume":"13","author":"Mishra","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0715","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.4049\/jimmunol.1303185","article-title":"Mycobacterium tuberculosis impairs dendritic cell functions through the serine hydrolase Hip1","volume":"192","author":"Madan-Lala","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0720","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41385-021-00471-x","article-title":"Mucosal tissue regulatory T cells are integral in balancing immunity and tolerance at portals of antigen entry","volume":"15","author":"Traxinger","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0725","doi-asserted-by":"crossref","first-page":"60710","DOI":"10.18632\/oncotarget.19940","article-title":"SOCS molecules: the growing players in macrophage polarization and function","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2025.115455_bb0730","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.747799","article-title":"Macrophage: a cell with many faces and functions in tuberculosis","volume":"13","author":"Ahmad","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0735","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.820134","article-title":"In the thick of it: formation of the tuberculous granuloma and its effects on host and therapeutic responses","volume":"13","author":"Cronan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0740","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-0716-0872-2_4","article-title":"CpG oligonucleotides as vaccine adjuvants","volume":"2197","author":"Kayraklioglu","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.intimp.2025.115455_bb0745","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2174\/1389203720666190830162149","article-title":"Single stranded DNA immune modulators with Unmethylated CpG motifs: structure and molecular recognition by toll-like receptor 9","volume":"20","author":"Feh\u00e9r","year":"2019","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.intimp.2025.115455_bb0750","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.2147\/IJN.S317626","article-title":"CpG-based Nanovaccines for Cancer immunotherapy","volume":"16","author":"Chen","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2025.115455_bb0755","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1039\/D2RA06334D","article-title":"Macrophage-targeted nanoparticles mediate synergistic photodynamic therapy and immunotherapy of tuberculosis","volume":"13","author":"Tian","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.intimp.2025.115455_bb0760","doi-asserted-by":"crossref","first-page":"802","DOI":"10.37871\/jbres1517","article-title":"A new CpG ODN induces a Fine-tuning of innate response resulting in Mycobacterium tuberculosis containment","volume":"3","author":"Cappelli","year":"2022","journal-title":"J Biomed Res Environ Sci"},{"key":"10.1016\/j.intimp.2025.115455_bb0765","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejpb.2023.04.005","article-title":"Method of manufacturing CAF\u00ae09 liposomes affects immune responses induced by adjuvanted subunit proteins","volume":"189","author":"Thakur","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.intimp.2025.115455_bb0770","doi-asserted-by":"crossref","DOI":"10.3791\/62255","article-title":"Phase change Dimethyldioctadecylammonium-shelled microdroplets as a promising drug delivery system: results on 3D spheroids of mammalian tumor cells","author":"Tortorella","year":"2021","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.intimp.2025.115455_bb0775","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2018.06.028","article-title":"Immune responses induced by nano-self-assembled lipid adjuvants based on a monomycoloyl glycerol analogue after vaccination with the chlamydia trachomatis major outer membrane protein","volume":"285","author":"Rodrigues","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2025.115455_bb0780","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4161\/cbt.10.12.13450","article-title":"Anticancer function of polyinosinic-polycytidylic acid","volume":"10","author":"Cheng","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.intimp.2025.115455_bb0785","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/j.vaccine.2014.05.050","article-title":"Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant","volume":"32","author":"Korsholm","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2025.115455_bb0790","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12272-019-01167-4","article-title":"Phosphatidylserine receptor-targeting therapies for the treatment of cancer","volume":"42","author":"Park","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.intimp.2025.115455_bb0795","first-page":"272","article-title":"Evaluation of vitamin status in patients with pulmonary tuberculosis","volume":"74","author":"Oh","year":"2017","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.intimp.2025.115455_bb0800","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/cix476","article-title":"Impact of vitamin a and carotenoids on the risk of tuberculosis progression","volume":"65","author":"Aibana","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2025.115455_bb0805","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3390\/antibiotics10111354","article-title":"Potential role of vitamins a, B, C, D and E in TB treatment and prevention: a narrative review","volume":"10","author":"Patti","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.intimp.2025.115455_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113451","article-title":"Overview of all-trans-retinoic acid (ATRA) and its analogues: structures, activities, and mechanisms in acute promyelocytic leukaemia","volume":"220","author":"Liang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2025.115455_bb0815","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03683-21","article-title":"CRISPR Interference Reveals That All-Trans-Retinoic Acid Promotes Macrophage Control of Mycobacterium tuberculosis by Limiting Bacterial Access to Cholesterol and Propionyl Coenzyme A","volume":"13","author":"Babunovic","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.intimp.2025.115455_bb0820","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/pharmaceutics12080707","article-title":"Current trends in ATRA delivery for Cancer therapy","volume":"12","author":"Giuli","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2025.115455_bb0825","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.873890","article-title":"The Progress of the prevention and treatment of vitamin D to tuberculosis","volume":"9","author":"Cai","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.intimp.2025.115455_bb0830","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00327-19","article-title":"Vitamin A Metabolism by Dendritic Cells Triggers an Antimicrobial Response against Mycobacterium tuberculosis","volume":"4","author":"Kim","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.intimp.2025.115455_bb0835","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2025.115455_bb0840","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3389\/fimmu.2017.01134","article-title":"What have we learnt about BCG vaccination in the last 20years?","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0845","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/cid\/ciac881","article-title":"VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including Coronavirus Disease 2019 In the elderly: a phase 3 randomized, double-blind, placebo-controlled, multicenter clinical study","volume":"76","author":"Blossey","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2025.115455_bb0850","article-title":"Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection","volume":"2","author":"Dijkman","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.intimp.2025.115455_bb0855","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","article-title":"The recombinant Bacille Calmette-Gu\u00e9rin vaccine VPM1002: ready for clinical efficacy testing","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0860","doi-asserted-by":"crossref","first-page":"e00100","DOI":"10.1128\/CMR.00100-19","article-title":"Tuberculosis vaccine development: Progress in clinical evaluation","volume":"33","author":"Sable","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.intimp.2025.115455_bb0865","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.935444","article-title":"Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations","volume":"13","author":"Baldwin","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2025.115455_bb0870","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/vaccines10050825","article-title":"Therapeutic effect of subunit vaccine AEC\/BC02 on Mycobacterium tuberculosis post-chemotherapy relapse using a latent infection murine model","volume":"10","author":"Lu","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.intimp.2025.115455_bb0875","article-title":"MVA85A vaccine to enhance BCG for preventing tuberculosis","volume":"4","author":"Kashangura","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.intimp.2025.115455_bb0880","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41467-022-28234-7","article-title":"Cost-effectiveness of routine adolescent vaccination with an M72\/AS01E-like tuberculosis vaccine in South Africa and India","volume":"13","author":"Harris","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115455_bb0885","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.1038\/s41467-021-27029-6","article-title":"A phase I\/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients","volume":"12","author":"Jenum","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115455_bb0890","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3390\/vaccines8040652","article-title":"Safety and immunogenicity of the GamTBvac, the recombinant subunit tuberculosis vaccine candidate: a phase II, multi-center, double-blind, randomized, placebo-controlled study","volume":"8","author":"Tkachuk","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.intimp.2025.115455_bb0895","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b Controlled Trial of M72\/AS01E Vaccine to Prevent Tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115455_bb0900","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1007\/s00253-023-12715-w","article-title":"Establishment of an indirect ELISA for Mycobacterium tuberculosis MTB39A protein antibody","volume":"107","author":"Wang","year":"2023","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.intimp.2025.115455_bb0905","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final Analysis of a Trial of M72\/AS01E Vaccine to Prevent Tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115455_bb0910","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/S1473-3099(23)00758-2","article-title":"TB042 study team, Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control","volume":"24","author":"Wajja","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.intimp.2025.115455_bb0915","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"MVA85A 020 trial study team, safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.115455_bb0920","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final Analysis of a Trial of M72\/AS01E Vaccine to Prevent Tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115455_bb0925","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.878471","article-title":"Therapeutic vaccines for tuberculosis: an overview","volume":"13","author":"Bouzeyen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb0930","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1080\/02770903.2020.1761381","article-title":"Mycobacterium vaccae nebulization protects Balb\/c mice against bronchial asthma through neural mechanisms","volume":"58","author":"Jiang","year":"2021","journal-title":"J. Asthma"},{"key":"10.1016\/j.intimp.2025.115455_bb0935","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089612","article-title":"Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection","volume":"9","author":"Nell","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.115455_bb0940","series-title":"Patient-Specific Models of Treatment Effects Explain Heterogeneity in Tuberculosis","author":"Wu","year":"2024"},{"key":"10.1016\/j.intimp.2025.115455_bb0945","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jcyt.2020.12.014","article-title":"Estimation of manufacturing development costs of cell-based therapies: a feasibility study","volume":"23","author":"Ten Ham","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.intimp.2025.115455_bb0950","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193596","article-title":"Ag85-focused T-cell immune response controls Mycobacterium avium chronic infection","volume":"13","author":"Cerqueira-Rodrigues","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.115455_bb0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2022.123927","article-title":"Rapid electrochemical detection of Mycobacterium tuberculosis in sputum by measuring Ag85 activity with disposable carbon sensors","volume":"253","author":"Barbier","year":"2023","journal-title":"Talanta"},{"key":"10.1016\/j.intimp.2025.115455_bb0960","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.trsl.2020.03.007","article-title":"New tuberculosis drug targets, their inhibitors, and potential therapeutic impact","volume":"220","author":"Shetye","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.intimp.2025.115455_bb0965","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300099","article-title":"DprE1 inhibitors: enduring aspirations for future Antituberculosis drug discovery","volume":"18","author":"Yadav","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.intimp.2025.115455_bb0970","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00597-23","article-title":"Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB\/FeJ mouse tuberculosis model","volume":"67","author":"Ramey","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2025.115455_bb0975","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02165-17","article-title":"Vitamin C potentiates the killing of Mycobacterium tuberculosis by the first-line tuberculosis drugs isoniazid and rifampin in mice","volume":"62","author":"Vilch\u00e8ze","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2025.115455_bb0980","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/biof.1932","article-title":"Effect of nano-curcumin on various diseases: a comprehensive review of clinical trials","volume":"49","author":"Hassanizadeh","year":"2023","journal-title":"Biofactors"},{"key":"10.1016\/j.intimp.2025.115455_bb0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2023.105279","article-title":"Bioactives from medicinal herb against bedaquiline resistant tuberculosis: removing the dark clouds from the horizon","volume":"26","author":"Singh","year":"2024","journal-title":"Microbes Infect."},{"key":"10.1016\/j.intimp.2025.115455_bb0990","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1277178","article-title":"Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections","volume":"14","author":"Ouyang","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2025.115455_bb0995","first-page":"427","article-title":"The use of immunotherapy for the treatment of tuberculosis, expert rev","volume":"12","author":"Ramos-Espinosa","year":"2018","journal-title":"Respir. Med."},{"key":"10.1016\/j.intimp.2025.115455_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110109","article-title":"Thymopentin (TP-5) prevents lipopolysaccharide-induced neuroinflammation and dopaminergic neuron injury by inhibiting the NF-\u03baB\/NLRP3 signaling pathway","volume":"119","author":"Peng","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115455_bb1005","doi-asserted-by":"crossref","first-page":"RP91930","DOI":"10.7554\/eLife.91930.3","article-title":"ESAT-6 undergoes self-association at phagosomal pH and an ESAT-6-specific nanobody restricts M. tuberculosis growth in macrophages","volume":"12","author":"Bates","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2025.115455_bb1010","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2217\/fmb-2019-0347","article-title":"Detection of mycobacterial CFP-10 (Rv3874) protein in tuberculosis patients by gold nanoparticle-based real-time immuno-PCR","volume":"15","author":"Dahiya","year":"2020","journal-title":"Future Microbiol."},{"key":"10.1016\/j.intimp.2025.115455_bb1015","series-title":"Identification of Anti-Lipoarabinomannan Antibodies against Mannan Core and their Effects on Phagocytosis of Mycobacteria by Human Neutrophils, Tuberculosis","first-page":"132","author":"N. H, O. E, H. T, H. K, N. K, Y. N, O. H, T. K, I. K","year":"2022"},{"key":"10.1016\/j.intimp.2025.115455_bb1020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00216-018-1466-z","article-title":"Epitope and affinity determination of recombinant Mycobacterium tuberculosis Ag85B antigen towards anti-Ag85 antibodies using proteolytic affinity-mass spectrometry and biosensor analysis","volume":"411","author":"Rinaldi","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.intimp.2025.115455_bb1025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181714","article-title":"Detection of anti-HspX antibodies and HspX protein in patient sera for the identification of recent latent infection by Mycobacterium tuberculosis","volume":"12","author":"Castro-Garza","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.115455_bb1030","doi-asserted-by":"crossref","first-page":"eabh2841","DOI":"10.1126\/science.abh2841","article-title":"Tumor necrosis factor induces pathogenic mitochondrial ROS in tuberculosis through reverse electron transport","volume":"376","author":"Roca","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.115455_bb1035","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.3389\/fimmu.2019.03103","article-title":"Interleukin-2-inducible T-cell kinase deficiency impairs early pulmonary protection against Mycobacterium tuberculosis infection","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb1040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1447161","article-title":"Cytokine and chemokine profiles in pulmonary tuberculosis with pre-diabetes","volume":"15","author":"Rajamanickam","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb1045","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12743","article-title":"Immunotherapeutic effects of recombinant adenovirus encoding interleukin 12 in experimental pulmonary tuberculosis","volume":"89","author":"Mata-Espinosa","year":"2019","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2025.115455_bb1050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/jcpe.13258","article-title":"NLRP3 inflammasome mediates M1 macrophage polarization and IL-1\u03b2 production in inflammatory root resorption","volume":"47","author":"Zhang","year":"2020","journal-title":"J. Clin. Periodontol."},{"key":"10.1016\/j.intimp.2025.115455_bb1055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/jir.2018.0164","article-title":"Transforming growth factor-\u03b2 suppresses interleukin (IL)-2 and IL-1\u03b2 production in HIV-tuberculosis co-infection","volume":"39","author":"Devalraju","year":"2019","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.intimp.2025.115455_bb1060","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s42003-022-04265-0","article-title":"Mycobacterium tuberculosis senses host interferon-\u03b3 via the membrane protein MmpL10","volume":"5","author":"Ahmed","year":"2022","journal-title":"Commun Biol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925014468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925014468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T15:13:32Z","timestamp":1763046812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925014468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":212,"alternative-id":["S1567576925014468"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115455","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host-directed immunotherapy to enhance treatment of Mycobacterium tuberculosis infection","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115455"}}